Evidence map›Paper›PMID 41931620›Full record

ArticleScience advances2026

Phospholipid-driven conformational switching of HCV NS5A links protein folding to replication membrane remodeling.

Anna V Bulankina, Rebecca M Richter, James H Nettles, Daisuke Yamane, Christian Grimm, Yasaman Karami, Richard A Stanton, Bianca Introini, Jonas Hermann, Hanaa Charif and 15 more

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Anna V BulankinaGoethe University Frankfurt, University Hospital, Medical Clinic 1, Frankfurt/Main, Germany.ORCID 0009-0003-0992-7320
Rebecca M RichterGoethe University Frankfurt, University Hospital, Medical Clinic 1, Frankfurt/Main, Germany.ORCID 0000-0002-3831-7666
James H NettlesCenter for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, USA.ORCID 0000-0002-5683-8481
Daisuke YamaneTokyo Metropolitan Institute of Medical Science, Tokyo, Japan.ORCID 0000-0003-1592-9368
Christian GrimmGoethe University Frankfurt, University Hospital, Medical Clinic 1, Frankfurt/Main, Germany.
Yasaman KaramiLorraine University, LORIA Institute, CNRS, INRIA, Nancy, France.ORCID 0000-0001-8413-2665
Richard A StantonCenter for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, USA.ORCID 0000-0003-4810-7002
Bianca IntroiniMax Planck Institute of Biophysics, Frankfurt/Main, Germany.
Jonas HermannGoethe University Frankfurt, University Hospital, Medical Clinic 1, Frankfurt/Main, Germany.
Hanaa CharifGoethe University Frankfurt, University Hospital, Medical Clinic 1, Frankfurt/Main, Germany.
Mia S KönigGoethe University Frankfurt, University Hospital, Medical Clinic 1, Frankfurt/Main, Germany.ORCID 0009-0009-5173-1798
Claudia StroßGoethe University Frankfurt, University Hospital, Medical Clinic 1, Frankfurt/Main, Germany.
Cristina OrtizGoethe University Frankfurt, University Hospital, Medical Clinic 1, Frankfurt/Main, Germany.
Nico KrausGoethe University Frankfurt, University Hospital, Medical Clinic 1, Frankfurt/Main, Germany.ORCID 0000-0002-5162-1048
Daniel WoodMax Planck Institute of Biophysics, Frankfurt/Main, Germany.
Facundo GalceranInstituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE), Buenos Aires, Argentina.ORCID 0000-0001-5023-0582
Rupert AbeleInstitute of Biochemistry, Biocenter, Goethe University, Frankfurt/Main, Germany.ORCID 0000-0001-6899-293X
Bernard MaigretLorraine University, LORIA Institute, CNRS, INRIA, Nancy, France.ORCID 0000-0002-1983-1950
Raymond F SchinaziCenter for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, USA.ORCID 0000-0002-6688-3614
Stefan ZeuzemGoethe University Frankfurt, University Hospital, Medical Clinic 1, Frankfurt/Main, Germany.
Ricardo M BiondiInstituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE), Buenos Aires, Argentina.ORCID 0000-0002-8873-7167
MinKyung YiDepartment of Microbiology and Immunology, University of Texas Medical Branch at Galveston, Galveston, TX, USA.
Robert TampéInstitute of Biochemistry, Biocenter, Goethe University, Frankfurt/Main, Germany.ORCID 0000-0002-0403-2160
Mikhail KudryashevMax Planck Institute of Biophysics, Frankfurt/Main, Germany.
Christoph WelschGoethe University Frankfurt, University Hospital, Medical Clinic 1, Frankfurt/Main, Germany.ORCID 0000-0002-1823-4863

Funding

Mechanistic function of HCV NS5A targeted by the potent inhibitorsR01AI146227 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI YI, MINKYUNG · 2020 to 2024
$2.8M
NIAID NIH HHS R01 AI146227
6 · The paper itself

Abstract

Phospholipids are essential for RNA virus replication, yet their role in modulating conformational dynamics of membrane-associated viral proteins remains poorly understood. For NS5A, a key replication factor of hepatitis C virus, previous crystallographic models fail to capture the lipid-driven conformational mechanics we uncover here. Using structural informatics and biochemical probing of pharmacophore-guided mutants in defined lipid environments, we evaluated competing NS5A domain 1 dimerization models. Our data reveal an alternative membrane-specific fold stabilized by polyproline hinges and phospholipids (PIPs) such as phosphatidylinositol-4-phosphate, a host lipid enriched at replication membranes. PIP binding promotes a conformational switch that drives dimerization, linking lipid sensing to membrane remodeling and host factor recruitment. This reciprocal mechanism-where a lipid allosterically modulates a viral protein that reshapes membranes-is blocked by the antiviral pibrentasvir. These findings define a lipid-driven structural switch that governs NS5A pleiotropy and highlight dynamic lipid-protein interfaces as targets for antiviral intervention.

Indexed as

Cell MembraneHepacivirusPhospholipidsProtein FoldingViral Nonstructural ProteinsVirus ReplicationHumansModels, MolecularProtein ConformationRNA-Dependent RNA PolymeraseNS-5 protein, hepatitis C virusPhospholipidsRNA-Dependent RNA PolymeraseViral Nonstructural Proteins

Identifiers

PMID41931620
PMCPMC13048264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.